Severe spontaneous arterial thrombotic manifestations in patients with inherited hypo- and afibrinogenemia

Haemophilia

Volumn 15, Issue 2, 2009, Pages 533-537

  Castaman, Giancarlo ^a   Lunardi, M ^b   Rigo, L ^b   Mastroeni, V ^b   Bonoldi, E ^a   Rodeghiero, F ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Afibrinogenemia; Arterial thrombosis; Fibrinogen disorders; Inherited bleeding disorders

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 5 LEIDEN; C REACTIVE PROTEIN; CORTICOSTEROID; DALTEPARIN; ENOXAPARIN; ESTROGEN DERIVATIVE; FIBRINOGEN; HEPARIN; ILOPROST; LEUPRORELIN; LOW MOLECULAR WEIGHT HEPARIN; METHYLPREDNISOLONE; UROKINASE;

ABDOMINAL PAIN; ADULT; AFIBRINOGENEMIA; ARTERIOGRAPHY; ARTERY THROMBOSIS; ARTICLE; BLEEDING TIME; BLOOD CLOT LYSIS; CASE REPORT; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; FOOT PAIN; HEMARTHROSIS; HEMOPERITONEUM; HEPATITIS C; HUMAN; HYPOFIBRINOGENEMIA; LOW DRUG DOSE; LUNG SURGERY; MISSENSE MUTATION; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY VALVE STENOSIS; SINGLE DRUG DOSE; SPONTANEOUS ABORTION; THROMBOCYTE COUNT; TIBIAL ARTERY;

ADULT; AFIBRINOGENEMIA; AMPUTATION; ANGIOGRAPHY; FEMALE; FIBRINOGEN; FOOT; HUMANS; MIDDLE AGED; RENAL ARTERY; THROMBOSIS; TIBIAL ARTERIES; TREATMENT OUTCOME;

EID: 63349105369     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.01939.x     Document Type: Article

References (13)

1. Asselta R, Duga S, Tenchini ML. The molecular basis of quantitative fibrinogen disorders. J Thromb Haemost 2006; 4: 1-15.
2. Peyvandi F, Haertel S, Knaub S, Mannucci PM. Incidence of bleeding symptoms in 100 patients with inherited afibrinogenemia or hypofibrinogenemia. J Thromb Haemost 2006; 4: 1634-7.
3. Girolami A, Ruzzon E, Tezza F, Scandellari R, Vettore S, Girolami B. Arterial and venous thrombosis in rare congenital bleeding disorders: A critical review. Haemophilia 2006; 12: 345-51.
4. Castaman G, Rodeghiero F. Failure of DDAVP to shorten the prolonged bleeding time of two patients with congenital afibrinogenemia. Thromb Res 1992; 68: 309-11.
5. Spena S, Asselta R, Platè M, Castaman G, Duga S, Tenchini ML. Pseudo-exon activation caused by a deep-intronic mutation in the fibrinogen γ-chain gene as a novel mechanism for congenital afibrinogenaemia. Br J Haematol 2007; 139: 128-32.
6. Castaman G, Ruggeri M, Rodeghiero F. Congenital afibrinogenemia: successful prevention of recurrent hemoperitoneum during ovulation by oral contraceptive. Am J Hematol 1995; 49: 363-4.
7. Barbui T, Porciello PI, Dini E. Coagulation studies in a case of severe congenital hypofibrinogenemia. Thromb Diath Haemorrh 1972; 28: 129-34.
8. Asselta R, Duga S, Spena S et al. Missense or splicing mutation? The case of a fibrinogen Bβ-chain mutation causing severe hypofibrinogenemia. Blood 2004; 103: 3051-4.
9. Chafa O, Chellali T, Sternberg C, Reghis A, Hamladji RM, Fischer AM. Severe hypofibrinogenemia associated with bilateral ischemic necrosis of toes and fingers. Blood Coagul Fibrinolysis 1995; 6: 549-52.
10. Lak M, Keihani M, Elahi F, Peyvandi F, Mannucci PM. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol 1999; 107: 204-6.
11. Garcia-Monco JC, Fernandez Canton G, Gomez Beldarrian M. Bilateral vertebral artery dissection in a patient with afibrinogenemia. Stroke 1996; 27: 2325-7.
12. Hanano M, Takahashi H, Itoh M, Shibata A. Coexistence of congenital afibrinogenemia and protein C deficiency in a patient. Am J Hematol 1992; 41: 57-60.
13. Dupuy E, Soria C, Molho P et al. Embolized ischemic lesions of toes in an afibrinogenemic patient: Possible relevance to in vivo circulating thrombin. Thromb Res 2001; 102: 211-9.